Regulatory document
Time allowed for applicants to respond to questions and issues raised during the…
EMA · Information · EU · Dec 12, 2016
Key facts
| Title | Time allowed for applicants to respond to questions and issues raised during the assessment of new marketing authorisation applications in the centralised procedure |
|---|---|
| Issuer | European Medicines Agency |
| Source | EMA |
| Document type | Information |
| Country or region | EU |
| Date | Dec 12, 2016 |
| Document | ema.europa.eu |
| Issuer website | ema.europa.eu |
At a glance
- Yes Full text searchable in Orca1
- 1,000+ Documents from this issuer in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Global regulations and guidance
Regulations, guidance and official notices from medical device and medicines regulators worldwide, collected by Orca1 from each issuer's website. Only the title, issuer, date and link are shown here; the full text is searchable in Orca1.
Source: Medical device and medicines regulators and agencies as named on each record (EMA, MHRA, TGA, CDSCO, PMDA, NMPA, Health Canada, HSA, the FDA and others), collected by Orca1 from each issuer's website · Source date: